{
    "medicine_id": "3b6c2ec4aedb88f4a98f3ab817a3f8262e5ff3f1",
    "platform_id": "10249",
    "metadata": {
        "name": "Soltel CFC free Inhaler 25 micrograms per actuation pressurised inhalation suspension",
        "composition": "Each metered dose ex valve contains 25 micrograms salmeterol as xinafoate This is equivalent to a delivered dose ex actuator of 21 micrograms salmeterol as xinafoate",
        "clinical_particulars": {
            "therapeutic_indications": "Asthma Soltel CFC free Inhaler is indicated for the regular symptomatic add on treatment of reversible airways obstruction in patients with asthma including those with nocturnal asthma who are inadequately controlled on inhaled corticosteroids in accordance with current treatment guidelines Chronic obstructive pulmonary disease COPD Soltel CFC free Inhaler is indicated in the treatment of chronic obstructive pulmonary disease COPD Prevention of exercise induced asthma",
            "contraindications": {
                "disease": "Hypersensitivity to salmeterol xinafoate or to any of the excipients listed in see section 6 1 Excipients Soltel CFC free Inhaler 25 micrograms contains soya lecithin and is contraindicated in patients who have peanut or soya allergies",
                "pregnancy": "Applicable",
                "machine_ops": "Applicable",
                "excipients": "Anhydrous ethanol;Soya lecithin (E322);Norflurane (HFA 134a), a hydrofluoroalkane (non-chlorofluorocarbon) propellant.;This product does not contain any chlorofluorocarbon propellants.",
                "incompatibilities": "Not applicable."
            }
        },
        "revision_date": "2022-07-03"
    }
}